580
The mild immunosuppression that occurs with methotrexate therapy probably places patients with rheumatoid arthritis at added risk of developing lymphoproliferative diseases, but coincidence cannot be excluded.
 patients with rheumatoid arthritis: Subject; mild immunosuppression: Effect; lymphoproliferative diseases: Effect; methotrexate: Treatment; rheumatoid arthritis: Treatment.Disorder; methotrexate: Treatment.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 patients with rheumatoid arthritis: Subject; mild immunosuppression: Effect; lymphoproliferative diseases: Effect; methotrexate: Treatment; rheumatoid arthritis: Treatment.Disorder; methotrexate: Treatment.Drug